Create a professional, distinction-level MSc academic poster titled: Antimicrobial Resistance at the Human–Animal–Environment Interface: A Critical One Health Approach to a Global Health Threat Design a landscape A0 academic poster suitable for a five-minute university presentation. Use a clean, modern scientific design with a white background, dark navy headings, teal and green accents, readable typography and three balanced columns. 1. Background and significance Antimicrobial resistance occurs when bacteria, viruses, fungi or parasites no longer respond adequately to medicines designed to treat them. This poster focuses primarily on antibiotic resistance in bacteria, for which the strongest current global surveillance data are available. AMR can make common infections harder to treat and increase the risks associated with surgery, cancer treatment and other medical interventions. It is driven by the misuse and overuse of antimicrobials, inadequate infection prevention, limited diagnostic access and the spread of resistant organisms. World Health Organization +1 2. Global evidence: why action is urgent 1 in 6 Laboratory-confirmed bacterial infections were resistant to antibiotic treatments globally in 2023. 4.7m+ Deaths globally were associated with bacterial AMR in 2021. 104 countries Reported data used in WHO's 2025 global resistance report for 2023. 2026–2036 Period covered by the updated WHO Global Action Plan on AMR adopted in May 2026. Sources: WHO (2025, 2026). The death estimate refers to 2021; the resistance prevalence refers to 2023. These are different measures and years, not a single current-year estimate. World Health Organization +2 3. AMR through a One Health lens HUMAN HEALTH Unnecessary prescriptions, inappropriate self-medication, poor infection control and inadequate diagnostic access. ANIMAL HEALTH AND FOOD SYSTEMS Antimicrobial use in livestock and aquaculture can select resistant organisms; transmission can occur through contact, food and waste. ENVIRONMENTAL HEALTH Poorly managed sewage, wastewater, manure and pharmaceutical waste can introduce resistant organisms and antimicrobial residues into ecosystems. These pathways are interconnected; the diagram illustrates plausible transmission routes, not proof that every route contributes equally in every setting. Food and Agriculture Organization +2 4. Critical analysis: what is missing from current responses? - Fragmented surveillance: Human clinical data alone cannot identify all reservoirs and transmission pathways across livestock, food and wastewater. - Prevention versus restriction: Reducing inappropriate use is essential, but indiscriminate restrictions can harm patients and animals who genuinely need treatment. - Environmental blind spots: Prescribing controls will have limited reach if resistant organisms and antimicrobial residues continue entering inadequately treated waste streams. - Unequal capacity: Countries with limited d
Create a professional, distinction-level MSc academic poster titled: Antimicrobial Resistance at the Human–Animal–Environment Interface: A Critical One Health Approach to a Global Health Threat Design a landscape A0 academic poster suitable for a five-minute university presentation. Use a clean, modern scientific design with a white background, dark navy headings, teal and green accents, readable typography and three balanced columns. 1. Background and significance Antimicrobial resistance occurs when bacteria, viruses, fungi or parasites no longer respond adequately to medicines designed to treat them. This poster focuses primarily on antibiotic resistance in bacteria, for which the strongest current global surveillance data are available. AMR can make common infections harder to treat and increase the risks associated with surgery, cancer treatment and other medical interventions. It is driven by the misuse and overuse of antimicrobials, inadequate infection prevention, limited diagnostic access and the spread of resistant organisms. World Health Organization +1 2. Global evidence: why action is urgent 1 in 6 Laboratory-confirmed bacterial infections were resistant to antibiotic treatments globally in 2023. 4.7m+ Deaths globally were associated with bacterial AMR in 2021. 104 countries Reported data used in WHO's 2025 global resistance report for 2023. 2026–2036 Period covered by the updated WHO Global Action Plan on AMR adopted in May 2026. Sources: WHO (2025, 2026). The death estimate refers to 2021; the resistance prevalence refers to 2023. These are different measures and years, not a single current-year estimate. World Health Organization +2 3. AMR through a One Health lens HUMAN HEALTH Unnecessary prescriptions, inappropriate self-medication, poor infection control and inadequate diagnostic access. ANIMAL HEALTH AND FOOD SYSTEMS Antimicrobial use in livestock and aquaculture can select resistant organisms; transmission can occur through contact, food and waste. ENVIRONMENTAL HEALTH Poorly managed sewage, wastewater, manure and pharmaceutical waste can introduce resistant organisms and antimicrobial residues into ecosystems. These pathways are interconnected; the diagram illustrates plausible transmission routes, not proof that every route contributes equally in every setting. Food and Agriculture Organization +2 4. Critical analysis: what is missing from current responses? - Fragmented surveillance: Human clinical data alone cannot identify all reservoirs and transmission pathways across livestock, food and wastewater. - Prevention versus restriction: Reducing inappropriate use is essential, but indiscriminate restrictions can harm patients and animals who genuinely need treatment. - Environmental blind spots: Prescribing controls will have limited reach if resistant organisms and antimicrobial residues continue entering inadequately treated waste streams. - Unequal capacity: Countries with limited d
Created using ChatSlide
Antimicrobial resistance (AMR) poses a critical threat, with 1 in 6 infections resisting treatment in 2023 and over 4.7 million deaths linked to AMR in 2021. Addressing this issue requires a comprehensive approach across the One Health interface, focusing on human health, animal use, and environmental impacts. An integrated response is essential, emphasizing unified surveillance, equitable access to treatments, and prioritizing prevention and diagnostics to combat this growing crisis.